AB
GH icon

Amalgamated Bank’s Guardant Health GH Stock Holding History

Amalgamated Bank’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
8,866
+5,048
+132% +$549K 0.01% 993
2026
Q1 		$353K Hold
3,818
– – ﹤0.01% 1434
2025
Q4 		$390K Sell
3,818
-52
-1% -$4.65K ﹤0.01% 1407
2025
Q3 		$242K Sell
3,870
-254
-6% -$13.8K ﹤0.01% 1527
2025
Q2 		$215K Hold
4,124
– – ﹤0.01% 1534
2025
Q1 		$176K Buy
4,124
+158
+4% +$6.82K ﹤0.01% 1559
2024
Q4 		$121K Hold
3,966
– – ﹤0.01% 1665
2024
Q3 		$91K Hold
3,966
– – ﹤0.01% 1722
2024
Q2 		$115K Buy
3,966
+178
+5% +$4.14K ﹤0.01% 1695
2024
Q1 		$78K Sell
3,788
-12,289
-76% -$263K ﹤0.01% 1769
2023
Q4 		$435K Sell
16,077
-981
-6% -$25.7K ﹤0.01% 1494
2023
Q3 		$506K Buy
17,058
+521
+3% +$18.3K ﹤0.01% 1404
2023
Q2 		$592K Sell
16,537
-3,811
-19% -$109K ﹤0.01% 1357
2023
Q1 		$477K Sell
20,348
-2,150
-10% -$61.4K ﹤0.01% 1440
2022
Q4 		$612K Buy
22,498
+334
+2% +$15.3K 0.01% 1371
2022
Q3 		$1.19M Buy
22,164
+385
+2% +$19.8K 0.01% 1039
2022
Q2 		$879K Buy
21,779
+907
+4% +$44.9K 0.01% 1197
2022
Q1 		$1.38M Buy
20,872
+1,897
+10% +$130K 0.01% 1079
2021
Q4 		$1.9M Buy
18,975
+2,714
+17% +$281K 0.01% 967
2021
Q3 		$2.03M Sell
16,261
-991
-6% -$118K 0.02% 915
2021
Q2 		$2.14M Buy
17,252
+2,050
+13% +$276K 0.02% 934
2021
Q1 		$2.32M Sell
15,202
-1,398
-8% -$211K 0.09% 187
2020
Q4 		$2.14M Buy
16,600
+1,411
+9% +$162K 0.08% 212
2020
Q3 		$1.7M Sell
15,189
-218
-1% -$19.9K 0.07% 240
2020
Q2 		$1.25M Buy
15,407
+5,773
+60% +$465K 0.06% 325
2020
Q1 		$671K Sell
9,634
-146
-1% -$11.2K 0.02% 773
2019
Q4 		$764K Buy
9,780
+1,074
+12% +$77.4K 0.01% 917
2019
Q3 		$556K Buy
8,706
+1,121
+15% +$98.8K 0.01% 995
2019
Q2 		$655K Buy
+7,585
New +$579K 0.02% 935

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Amalgamated Bank's GH Position: Q2 2026 in Review

Amalgamated Bank increased its Guardant Health (GH) stake by 132% in Q2 2026, buying an estimated $549K and bringing the position to 8,866 shares worth $1.33M. The position accounts for 0.01% of the portfolio, ranked #993.

Amalgamated Bank first reported a position in GH in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.32M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Amalgamated Bank held 8,866 shares of Guardant Health worth $1.33M as of Q2 2026.
  • Amalgamated Bank bought 5,048 Guardant Health shares in Q2 2026, an estimated $549K.
  • Guardant Health made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #993 holding.
  • Amalgamated Bank first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
  • Amalgamated Bank's Guardant Health position peaked at $2.32M in Q1 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.